Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(6/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(6/week)
News
United States
(507/week)
Manufacturing
(335/week)
Energy
(278/week)
Technology
(347/week)
Other Energy
(240/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Teplizumab
Jun 16, 2020
Provention Bio Announces Proposed Public Offering of Common Stock
Jun 15, 2020
Provention Bio's Teplizumab Continued to Significantly Delay the Onset of Insulin-Dependent Type 1 Diabetes (T1D) in Presymptomatic Patients
May 28, 2020
Provention Bio to Present at the Jefferies Virtual Healthcare Conference
May 20, 2020
Provention Bio Announces Changes to its Board of Directors
Apr 30, 2020
Provention Bio to Report First Quarter 2020 Financial Results and Host Conference Call on Thursday, May 7, 2020
Mar 16, 2020
Provention Bio Provides Update on the Status of Its Phase 3 PROTECT Study for the Treatment of Newly Diagnosed Type 1 Diabetes
Mar 12, 2020
Provention Announces Positive Data from Phase 1b PREVAIL Study of PRV-3279
Mar 12, 2020
Provention Bio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Mar 05, 2020
Provention Bio to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Thursday, March 12, 2020
Nov 05, 2019
Provention Bio Reports Third Quarter 2019 Financial Results
Sep 26, 2019
Sean Doherty Joins Provention Bio Board of Directors
Sep 24, 2019
Provention Bio Reiterates Regulatory Strategy for PRV-031 and Announces Completion of Follow-on Financing
Aug 20, 2019
Provention Bio Announces Key Addition to its Leadership Team
Aug 06, 2019
Provention Bio Reports Second Quarter 2019 Financial Results
Aug 05, 2019
Provention Bio Announces Breakthrough Therapy Designation for Teplizumab (PRV-031) for the Prevention or Delay of Clinical Type 1 Diabetes in At-Risk Individuals
Jul 10, 2019
MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China
Jul 01, 2019
ActoBio Therapeutics(TM) Progresses AG019 to Next Stage of a Phase Ib/IIa Clinical Study for the Treatment of Type 1 Diabetes
Jun 09, 2019
TrialNet Announces Type 1 Diabetes Prevention Breakthrough--
Jun 09, 2019
Teplizumab Delays Clinical Diagnosis of Type 1 Diabetes an Average of Two Years, According to Study Presented at ADA's Scientific Sessions
Jun 09, 2019
A Single Course of Provention's PRV-031 (Teplizumab) Delays Type 1 Diabetes Onset in High-Risk Individuals by at Least Two Years
Page 1
››
Latest News
Apr 20, 2024
H2 Green Mining and Ohmium Sign Agreement to Boost Green Hydrogen in Chile
Apr 19, 2024
Churchill Serves as Sole Lead Arranger for a First Lien Credit Facility to Support Wynnchurch Capital’s...
Apr 19, 2024
Global Small Modular Reactor Market for Data Centers Industry Report 2024-2033: Hyperscale Data Centers to...
Apr 19, 2024
BWXT Announces Expansion of Cambridge Manufacturing Plant to Support Global Nuclear Power Market
Apr 19, 2024
Chemtrade Logistics Income Fund Declares April 2024 Distribution
Apr 19, 2024
MCR and BLT Complete $632 Million Refinancing of 53-Hotel Portfolio
Apr 19, 2024
Avangrid Thanks Southern Connecticut Gas Employee for 51 Years of Service
Apr 19, 2024
Construction Equipment Global Strategic Business Report 2024: Market to Reach $248.5 Billion by 2030 - Focus...
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events